Bruh, they aren't RAC with a stall IP. The clinical trial they are conducting is revolutionary with multiple IP which is why RAC's R&D dwarfs that of IMU and why the FDA granted them Fast Track designation and ODD within 12-18 months when VAXINIA started. We will know whether we've back the wrong horse in 6 months time, right now for me the pps is very undervalue as the market hasn't value the fundamental in the last 12 months.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $89.60M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $140.7K | 11.61M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 9000852 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 6923007 | 25 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |